array:24 [
  "pii" => "S157821901730207X"
  "issn" => "15782190"
  "doi" => "10.1016/j.adengl.2016.11.020"
  "estado" => "S300"
  "fechaPublicacion" => "2017-07-01"
  "aid" => "1579"
  "copyright" => "Elsevier España, S.L.U. and AEDV"
  "copyrightAnyo" => "2017"
  "documento" => "simple-article"
  "crossmark" => 1
  "subdocumento" => "crp"
  "cita" => "Actas Dermosifiliogr. 2017;108:593-4"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 385
    "formatos" => array:3 [
      "EPUB" => 28
      "HTML" => 260
      "PDF" => 97
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:19 [
      "pii" => "S0001731017300133"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2016.11.015"
      "estado" => "S300"
      "fechaPublicacion" => "2017-07-01"
      "aid" => "1579"
      "copyright" => "AEDV"
      "documento" => "simple-article"
      "crossmark" => 1
      "subdocumento" => "crp"
      "cita" => "Actas Dermosifiliogr. 2017;108:593-4"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 752
        "formatos" => array:3 [
          "EPUB" => 54
          "HTML" => 221
          "PDF" => 477
        ]
      ]
      "en" => array:11 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letter</span>"
        "titulo" => "Refractory solar urticaria successfully treated with omalizumab with normalization of phototest"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "593"
            "paginaFinal" => "594"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "Urticaria solar refractaria tratada satisfactoriamente con omalizumab y normalizaci&#243;n del fototest"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0005"
            "etiqueta" => "Figure 1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr1.jpeg"
                "Alto" => 996
                "Ancho" => 990
                "Tamanyo" => 66330
              ]
            ]
            "descripcion" => array:1 [
              "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">&#40;A&#41; Phototest before omalizumab &#40;Waldman&#174; UV 181 UVA&#41; was positive for UVA&#44; minimal urticarial dose 7<span class="elsevierStyleHsp" style=""></span>J&#47;cm<span class="elsevierStyleSup">2</span>&#46; &#40;B&#41; Phototest after omalizumab &#40;Waldman&#174; UV 181 UVA&#41;&#58; no reaction occurred to UVA after 6 months of treatment&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "A&#46; Combalia, C&#46; Fern&#225;ndez-Sartorio, P&#46; Aguilera"
            "autores" => array:3 [
              0 => array:2 [
                "nombre" => "A&#46;"
                "apellidos" => "Combalia"
              ]
              1 => array:2 [
                "nombre" => "C&#46;"
                "apellidos" => "Fern&#225;ndez-Sartorio"
              ]
              2 => array:2 [
                "nombre" => "P&#46;"
                "apellidos" => "Aguilera"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S157821901730207X"
          "doi" => "10.1016/j.adengl.2016.11.020"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157821901730207X?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017300133?idApp=UINPBA000044"
      "url" => "/00017310/0000010800000006/v3_201707250313/S0001731017300133/v3_201707250313/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S1578219017301439"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2017.05.002"
    "estado" => "S300"
    "fechaPublicacion" => "2017-07-01"
    "aid" => "1575"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "crp"
    "cita" => "Actas Dermosifiliogr. 2017;108:595-7"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 691
      "formatos" => array:3 [
        "EPUB" => 40
        "HTML" => 555
        "PDF" => 96
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>"
      "titulo" => "Periarticular Thenar Erythema and Onycholysis Syndrome&#58; A Manifestation of Taxane-Induced Cutaneous Toxicity"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "595"
          "paginaFinal" => "597"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "S&#237;ndrome de eritema tenar periarticular y onicolisis&#58; una manifestaci&#243;n de toxicidad cut&#225;nea por taxanos"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0010"
          "etiqueta" => "Figure 2"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr2.jpeg"
              "Alto" => 1266
              "Ancho" => 950
              "Tamanyo" => 369100
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Histology of the lesion on the dorsum of the hand of patient<span class="elsevierStyleHsp" style=""></span>2&#46; A&#44; Hyperkeratotic epidermis with parakeratosis&#44; foci of vacuolar degeneration of the basal layer&#44; and a band-like perivascular infiltrate with occasional eosinophils&#46; Hematoxylin and eosin&#44; original magnification &#215;10&#46; B&#44; At higher power&#44; evidence of necrotic keratinocytes in the epidermis&#46; Hematoxylin and eosin&#44; original magnification<span class="elsevierStyleHsp" style=""></span>&#215;40&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "E&#46; Rodr&#237;guez-Lomba, I&#46; Molina-L&#243;pez, R&#46; Su&#225;rez-Fern&#225;ndez, O&#46; Baniandr&#233;s-Rodr&#237;guez"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "E&#46;"
              "apellidos" => "Rodr&#237;guez-Lomba"
            ]
            1 => array:2 [
              "nombre" => "I&#46;"
              "apellidos" => "Molina-L&#243;pez"
            ]
            2 => array:2 [
              "nombre" => "R&#46;"
              "apellidos" => "Su&#225;rez-Fern&#225;ndez"
            ]
            3 => array:2 [
              "nombre" => "O&#46;"
              "apellidos" => "Baniandr&#233;s-Rodr&#237;guez"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731016304446"
        "doi" => "10.1016/j.ad.2016.11.014"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731016304446?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017301439?idApp=UINPBA000044"
    "url" => "/15782190/0000010800000006/v1_201706300050/S1578219017301439/v1_201706300050/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S1578219017301440"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2017.05.003"
    "estado" => "S300"
    "fechaPublicacion" => "2017-07-01"
    "aid" => "1588"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "crp"
    "cita" => "Actas Dermosifiliogr. 2017;108:591-3"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 537
      "formatos" => array:3 [
        "EPUB" => 30
        "HTML" => 361
        "PDF" => 146
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letter</span>"
      "titulo" => "Azathioprine-Induced Hypersensitivity Reaction Presenting as Erythema Nodosum"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "591"
          "paginaFinal" => "593"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Eritema nudoso como reacci&#243;n de hipersensibilidad a la azatioprina"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1385
              "Ancho" => 1300
              "Tamanyo" => 196056
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Subcutaneous nodules with superficial erythema and erythematous-violaceous macules of residual appearance on the anterior and posterior aspects of both lower limbs&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "M&#46; Gonz&#225;lez-Olivares, R&#46; Khedaoui, C&#46; Mart&#237;nez-Mor&#225;n, J&#46; Borbujo"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "M&#46;"
              "apellidos" => "Gonz&#225;lez-Olivares"
            ]
            1 => array:2 [
              "nombre" => "R&#46;"
              "apellidos" => "Khedaoui"
            ]
            2 => array:2 [
              "nombre" => "C&#46;"
              "apellidos" => "Mart&#237;nez-Mor&#225;n"
            ]
            3 => array:2 [
              "nombre" => "J&#46;"
              "apellidos" => "Borbujo"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731017300443"
        "doi" => "10.1016/j.ad.2016.12.006"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017300443?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017301440?idApp=UINPBA000044"
    "url" => "/15782190/0000010800000006/v1_201706300050/S1578219017301440/v1_201706300050/en/main.assets"
  ]
  "en" => array:15 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letter</span>"
    "titulo" => "Refractory solar urticaria successfully treated with omalizumab with normalization of phototest"
    "tieneTextoCompleto" => true
    "saludo" => "Dear Editor&#44;"
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "593"
        "paginaFinal" => "594"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "A&#46; Combalia, C&#46; Fern&#225;ndez-Sartorio, P&#46; Aguilera"
        "autores" => array:3 [
          0 => array:4 [
            "nombre" => "A&#46;"
            "apellidos" => "Combalia"
            "email" => array:1 [
              0 => "andreacombalia&#64;gmail&#46;com"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "C&#46;"
            "apellidos" => "Fern&#225;ndez-Sartorio"
          ]
          2 => array:2 [
            "nombre" => "P&#46;"
            "apellidos" => "Aguilera"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Dermatology Department&#44; Hospital Cl&#237;nic de Barcelona&#44; Barcelona&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Urticaria solar refractaria tratada satisfactoriamente con omalizumab y normalizaci&#243;n del fototest"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 996
            "Ancho" => 990
            "Tamanyo" => 67385
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">&#40;A&#41; Phototest before omalizumab &#40;Waldman&#174; UV 181 UVA&#41; was positive for UVA&#44; minimal urticarial dose 7<span class="elsevierStyleHsp" style=""></span>J&#47;cm<span class="elsevierStyleSup">2</span>&#46; &#40;B&#41; Phototest after omalizumab &#40;Waldman&#174; UV 181 UVA&#41;&#58; no reaction occurred to UVA after 6 months of treatment&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Solar urticaria &#40;SU&#41; is a rare photodermatosis characterized by sudden onset of urticarial skin lesions&#44; intense itching or burning on photo-exposed areas&#44; occurring a few minutes after sun exposure with great impact on patients&#8217; quality of life&#46; It is considered a type I hypersensitivity reaction&#44; and therefore&#44; it is an immunoglobulin E &#40;IgE&#41;-mediated condition that may be accompanied by other systemic symptoms and signs&#44; such as dizziness&#44; headache and angioedema&#46; The action of spectrum for SU includes ultraviolet A &#40;UVA&#41;&#44; ultraviolet B &#40;UVB&#41;&#44; visible light &#40;VL&#41; and some patients may be sensitive to multiple action spectra&#46; Although the diagnosis is made by the characteristic clinical presentation&#44; it can be confirmed by phototesting&#46;<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">The treatment of choice consists in broad-spectrum sunscreens and high-dose H1-antihistamines&#59; however&#44; SU is often unresponsive to them&#46; Other treatment options are leukotriene receptor antagonists&#44; UV-hardening&#44; cyclosporine A&#44; antimalarial drugs&#44; plasmapheresis and intravenous immunoglobulin &#40;IVIG&#41;&#46; Efficacy of these treatments is usually partial or transient and may induce several unwanted effects&#44; i&#46;e&#46; anaphylaxis&#44; immunosuppression and malignancy&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">Omalizumab is a humanized monoclonal IgG1-kappa antibody against IgE recently approved by the US Food and Drug Administration and the European Medicines Agency for antihistamine refractory patients with chronic spontaneous urticaria &#40;CSU&#41; who are at least 12 years of age&#46;<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">2</span></a> Omalizumab binds to free IgE with a greater affinity than IgE itself binds to the high-affinity Fc¿RI receptors present on basophils&#46; Thus&#44; it reduces the availability of free IgE for binding and promotes down-regulation of Fc¿RI on the surface of mast cells and basophils preventing IgE-mediated histamine release&#46;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">We report a case of a previously healthy 21 year-old Caucasian female with a 4-year history of erythema&#44; intense itch&#44; swelling and hives after minimal sun exposure even through window glass&#46; No history of asthma or food allergy was reported&#46; Phototest performed on the patient&#39;s back &#40;Waldman&#174; UV 181 UVA and Waldman&#174; UV 800 broad band UVB&#41; was positive for UVA&#44; minimal urticarial dose 7<span class="elsevierStyleHsp" style=""></span>J&#47;cm<span class="elsevierStyleSup">2</span>&#44; and showed no reaction to UVB &#40;<a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#41;&#46; Visible light was not tested&#46; IgE serum levels were elevated &#40;294<span class="elsevierStyleHsp" style=""></span>kU&#47;L&#41; and other blood test determinations fell within normal limits&#59; cell count&#44; porphirins&#44; antinuclear antibodies&#44; liver and renal function panel&#44; and serum triptase&#46; She was diagnosed with Solar Urticaria &#40;SU&#41; induced by UVA&#44; and partially achieved to control symptoms with antihistamines &#40;Fexofenadine hydrochloride 180<span class="elsevierStyleHsp" style=""></span>mg&#47;day&#41; and broad-spectrum sunscreens&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0025" class="elsevierStylePara elsevierViewall">Three years after diagnosis&#44; her SU became unresponsive to first-line treatment with antihistamines&#44; even updosing up to 4-fold&#46; Her quality of life&#44; as assessed by the Dermatology Quality of Life Index &#40;DLQI 21&#41; was seriously affected by SU&#46; Thus&#44; after careful consideration we decided to try experimental therapy with omalizumab&#46; Following approval from our institution ethics committee for exceptional medical treatments&#44; an initial dose of 300<span class="elsevierStyleHsp" style=""></span>mg of omalizumab was administered in April 2015&#44; and antihistamines were gradually discontinued&#46; Subsequent doses of 300<span class="elsevierStyleHsp" style=""></span>mg were administered monthly&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">The patient reported a complete relief of symptoms within one day of the administration of the first dose &#40;DLQI 0&#41;&#46; She remained asymptomatic during the Spanish summer and no side effects were noted&#46; However&#44; a delay of omalizumab administration of one week brought back mild urticaria on one occasion&#46; We repeated the phototest six months later to check treatment response and no reaction occurred to either UVA or UVB spectrum &#40;<a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#41;&#46; One year later&#44; she is still on omalizumab and the effect is sustained&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">Treatment of SU with omalizumab is still off-label&#59; however&#44; management of SU with omalizumab has been proved effective on several occasions<a class="elsevierStyleCrossRefs" href="#bib0065"><span class="elsevierStyleSup">3&#8211;9</span></a> and promising clinical results have recently been published&#46;<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a></p><p id="par0040" class="elsevierStylePara elsevierViewall">On a recently published phase-II multicentric study&#44;<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a> the response rate of SU to omalizumab appeared close to the mean proportion of patients with CSU achieving a urticarial activity score over 7 days of 6 or less with the same dose of omalizumab&#44; and&#59; similar to what is observed in CSU&#44; the improvement in solar urticaria was rapidly lost when omalizumab was stopped&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">Omalizumab seems to be a new well-tolerated effective agent in the treatment of severe SU and might be soon included in SU treatment guidelines as a third-line therapy in the same way it is done with CSU&#46;</p><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflict of interest</span><p id="par0050" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflict of interest&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:2 [
        0 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Conflict of interest"
        ]
        1 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "multimedia" => array:1 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 996
            "Ancho" => 990
            "Tamanyo" => 67385
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">&#40;A&#41; Phototest before omalizumab &#40;Waldman&#174; UV 181 UVA&#41; was positive for UVA&#44; minimal urticarial dose 7<span class="elsevierStyleHsp" style=""></span>J&#47;cm<span class="elsevierStyleSup">2</span>&#46; &#40;B&#41; Phototest after omalizumab &#40;Waldman&#174; UV 181 UVA&#41;&#58; no reaction occurred to UVA after 6 months of treatment&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:10 [
            0 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The clinical and photobiological characteristics of solar urticaria in 40 patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "N&#46; Uetsu"
                            1 => "H&#46; Miyauchi-Hashimoto"
                            2 => "H&#46; Okamoto"
                            3 => "T&#46; Horio"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Dermatol"
                        "fecha" => "2000"
                        "volumen" => "142"
                        "paginaInicial" => "32"
                        "paginaFinal" => "38"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10651691"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The EAACI&#47;GA&#40;2&#41; LEN&#47;EDF&#47;WAO Guideline for the definition&#44; classification&#44; diagnosis&#44; and management of urticaria&#58; the 2013 revision and update"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "T&#46; Zuberbier"
                            1 => "W&#46; Aberer"
                            2 => "R&#46; Asero"
                            3 => "C&#46; Bindslev-Jensen"
                            4 => "Z&#46; Brzoza"
                            5 => "G&#46;W&#46; Canonica"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/all.12313"
                      "Revista" => array:6 [
                        "tituloSerie" => "Allergy"
                        "fecha" => "2014"
                        "volumen" => "69"
                        "paginaInicial" => "868"
                        "paginaFinal" => "887"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24785199"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Safety and tolerability of omalizumab &#40;Xolair&#174;&#41;&#44; a recombinant humanized monoclonal anti-IgE antibody"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "Y&#46;M&#46; Deniz"
                            1 => "N&#46; Gupta"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Rev Allergy Immunol"
                        "fecha" => "2005"
                        "volumen" => "29"
                        "paginaInicial" => "31"
                        "paginaFinal" => "48"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16222082"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Successful treatment of solar urticaria with anti-immunoglobulin E therapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "O&#46; G&#252;zelbey"
                            1 => "E&#46; Ardelean"
                            2 => "M&#46; Magerl"
                            3 => "T&#46; Zuberbier"
                            4 => "M&#46; Maurer"
                            5 => "M&#46; Metz"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1398-9995.2008.01879.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Allergy"
                        "fecha" => "2008"
                        "volumen" => "63"
                        "paginaInicial" => "1563"
                        "paginaFinal" => "1565"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18925897"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Church MK2Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria&#58; a retrospective clinical analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "M1 Metz"
                            1 => "T1 Ohanyan"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jdermsci.2013.08.011"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Dermatol Sci"
                        "fecha" => "2014"
                        "volumen" => "73"
                        "paginaInicial" => "57"
                        "paginaFinal" => "62"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24060603"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Three cases of solar urticaria successfully treated with omalizumab"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "C&#46; Baliu-Piqu&#233;"
                            1 => "P&#46; Aguilera Peir&#243;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:2 [
                        "tituloSerie" => "J Eur Acad Dermatol Venereol"
                        "fecha" => "2015"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Successful omalizumab treatment of severe solar urticaria in a 6-year-old child"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "A&#46; Levi"
                            1 => "Y&#46; Tal"
                            2 => "Z&#46; Dranitzki"
                            3 => "M&#46; Shalit"
                            4 => "C&#46;D&#46; Enk"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/pai.12441"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatr Allergy Immunol"
                        "fecha" => "2015 Sep"
                        "volumen" => "26"
                        "paginaInicial" => "588"
                        "paginaFinal" => "590"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26172942"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effectiveness of omalizumab in severe solar urticaria"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "&#193;&#46; De Dios-Vel&#225;zquez"
                            1 => "M&#46; Gonz&#225;lez-de Arriba"
                            2 => "V&#46; Beteta-Gorriti"
                            3 => "E&#46; Macias"
                            4 => "V&#46; Campanon-Toro"
                            5 => "I&#46; Davila"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.anai.2015.12.023"
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Allergy Asthma Immunol"
                        "fecha" => "2016"
                        "volumen" => "116"
                        "paginaInicial" => "260"
                        "paginaFinal" => "262"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26803538"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Treatment with omalizumab in a 16-year-old Caucasian girl with refractory solar urticaria"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46; Arasi"
                            1 => "G&#46; Crisafulli"
                            2 => "L&#46; Caminiti"
                            3 => "F&#46; Guarneri"
                            4 => "T&#46; Aversa"
                            5 => "F&#46; Porcaro"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/pai.12413"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatr Allergy Immunol"
                        "fecha" => "2015 Sep"
                        "volumen" => "26"
                        "paginaInicial" => "583"
                        "paginaFinal" => "585"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26033828"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Omalizumab in patients with severe and refractory solar urticaria&#58; a phase II multicentric study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "F&#46; Aubin"
                            1 => "M&#46; Avenel-Audran"
                            2 => "M&#46; Jeanmougin"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaad.2015.11.021"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Acad Dermatol"
                        "fecha" => "2016"
                        "volumen" => "74"
                        "paginaInicial" => "574"
                        "paginaFinal" => "575"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26892659"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/15782190/0000010800000006/v1_201706300050/S157821901730207X/v1_201706300050/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "6157"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Case and Research Letters"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010800000006/v1_201706300050/S157821901730207X/v1_201706300050/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157821901730207X?idApp=UINPBA000044"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Case and Research Letter
Refractory solar urticaria successfully treated with omalizumab with normalization of phototest
Urticaria solar refractaria tratada satisfactoriamente con omalizumab y normalización del fototest
A. Combalia
Corresponding author
andreacombalia@gmail.com

Corresponding author.
, C. Fernández-Sartorio, P. Aguilera
Dermatology Department, Hospital Clínic de Barcelona, Barcelona, Spain
Read
4556
Times
was read the article
1806
Total PDF
2750
Total HTML
Share statistics
 array:24 [
  "pii" => "S157821901730207X"
  "issn" => "15782190"
  "doi" => "10.1016/j.adengl.2016.11.020"
  "estado" => "S300"
  "fechaPublicacion" => "2017-07-01"
  "aid" => "1579"
  "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
  "copyrightAnyo" => "2017"
  "documento" => "simple-article"
  "crossmark" => 1
  "subdocumento" => "crp"
  "cita" => "Actas Dermosifiliogr. 2017;108:593-4"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 385
    "formatos" => array:3 [
      "EPUB" => 28
      "HTML" => 260
      "PDF" => 97
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:19 [
      "pii" => "S0001731017300133"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2016.11.015"
      "estado" => "S300"
      "fechaPublicacion" => "2017-07-01"
      "aid" => "1579"
      "copyright" => "AEDV"
      "documento" => "simple-article"
      "crossmark" => 1
      "subdocumento" => "crp"
      "cita" => "Actas Dermosifiliogr. 2017;108:593-4"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 752
        "formatos" => array:3 [
          "EPUB" => 54
          "HTML" => 221
          "PDF" => 477
        ]
      ]
      "en" => array:11 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letter</span>"
        "titulo" => "Refractory solar urticaria successfully treated with omalizumab with normalization of phototest"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "593"
            "paginaFinal" => "594"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "Urticaria solar refractaria tratada satisfactoriamente con omalizumab y normalizaci&#243;n del fototest"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0005"
            "etiqueta" => "Figure 1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr1.jpeg"
                "Alto" => 996
                "Ancho" => 990
                "Tamanyo" => 66330
              ]
            ]
            "descripcion" => array:1 [
              "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">&#40;A&#41; Phototest before omalizumab &#40;Waldman&#174; UV 181 UVA&#41; was positive for UVA&#44; minimal urticarial dose 7<span class="elsevierStyleHsp" style=""></span>J&#47;cm<span class="elsevierStyleSup">2</span>&#46; &#40;B&#41; Phototest after omalizumab &#40;Waldman&#174; UV 181 UVA&#41;&#58; no reaction occurred to UVA after 6 months of treatment&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "A&#46; Combalia, C&#46; Fern&#225;ndez-Sartorio, P&#46; Aguilera"
            "autores" => array:3 [
              0 => array:2 [
                "nombre" => "A&#46;"
                "apellidos" => "Combalia"
              ]
              1 => array:2 [
                "nombre" => "C&#46;"
                "apellidos" => "Fern&#225;ndez-Sartorio"
              ]
              2 => array:2 [
                "nombre" => "P&#46;"
                "apellidos" => "Aguilera"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S157821901730207X"
          "doi" => "10.1016/j.adengl.2016.11.020"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157821901730207X?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017300133?idApp=UINPBA000044"
      "url" => "/00017310/0000010800000006/v3_201707250313/S0001731017300133/v3_201707250313/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S1578219017301439"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2017.05.002"
    "estado" => "S300"
    "fechaPublicacion" => "2017-07-01"
    "aid" => "1575"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "crp"
    "cita" => "Actas Dermosifiliogr. 2017;108:595-7"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 691
      "formatos" => array:3 [
        "EPUB" => 40
        "HTML" => 555
        "PDF" => 96
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letters</span>"
      "titulo" => "Periarticular Thenar Erythema and Onycholysis Syndrome&#58; A Manifestation of Taxane-Induced Cutaneous Toxicity"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "595"
          "paginaFinal" => "597"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "S&#237;ndrome de eritema tenar periarticular y onicolisis&#58; una manifestaci&#243;n de toxicidad cut&#225;nea por taxanos"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0010"
          "etiqueta" => "Figure 2"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr2.jpeg"
              "Alto" => 1266
              "Ancho" => 950
              "Tamanyo" => 369100
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Histology of the lesion on the dorsum of the hand of patient<span class="elsevierStyleHsp" style=""></span>2&#46; A&#44; Hyperkeratotic epidermis with parakeratosis&#44; foci of vacuolar degeneration of the basal layer&#44; and a band-like perivascular infiltrate with occasional eosinophils&#46; Hematoxylin and eosin&#44; original magnification &#215;10&#46; B&#44; At higher power&#44; evidence of necrotic keratinocytes in the epidermis&#46; Hematoxylin and eosin&#44; original magnification<span class="elsevierStyleHsp" style=""></span>&#215;40&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "E&#46; Rodr&#237;guez-Lomba, I&#46; Molina-L&#243;pez, R&#46; Su&#225;rez-Fern&#225;ndez, O&#46; Baniandr&#233;s-Rodr&#237;guez"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "E&#46;"
              "apellidos" => "Rodr&#237;guez-Lomba"
            ]
            1 => array:2 [
              "nombre" => "I&#46;"
              "apellidos" => "Molina-L&#243;pez"
            ]
            2 => array:2 [
              "nombre" => "R&#46;"
              "apellidos" => "Su&#225;rez-Fern&#225;ndez"
            ]
            3 => array:2 [
              "nombre" => "O&#46;"
              "apellidos" => "Baniandr&#233;s-Rodr&#237;guez"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731016304446"
        "doi" => "10.1016/j.ad.2016.11.014"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731016304446?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017301439?idApp=UINPBA000044"
    "url" => "/15782190/0000010800000006/v1_201706300050/S1578219017301439/v1_201706300050/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S1578219017301440"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2017.05.003"
    "estado" => "S300"
    "fechaPublicacion" => "2017-07-01"
    "aid" => "1588"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "crp"
    "cita" => "Actas Dermosifiliogr. 2017;108:591-3"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 537
      "formatos" => array:3 [
        "EPUB" => 30
        "HTML" => 361
        "PDF" => 146
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letter</span>"
      "titulo" => "Azathioprine-Induced Hypersensitivity Reaction Presenting as Erythema Nodosum"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "591"
          "paginaFinal" => "593"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Eritema nudoso como reacci&#243;n de hipersensibilidad a la azatioprina"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1385
              "Ancho" => 1300
              "Tamanyo" => 196056
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Subcutaneous nodules with superficial erythema and erythematous-violaceous macules of residual appearance on the anterior and posterior aspects of both lower limbs&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "M&#46; Gonz&#225;lez-Olivares, R&#46; Khedaoui, C&#46; Mart&#237;nez-Mor&#225;n, J&#46; Borbujo"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "M&#46;"
              "apellidos" => "Gonz&#225;lez-Olivares"
            ]
            1 => array:2 [
              "nombre" => "R&#46;"
              "apellidos" => "Khedaoui"
            ]
            2 => array:2 [
              "nombre" => "C&#46;"
              "apellidos" => "Mart&#237;nez-Mor&#225;n"
            ]
            3 => array:2 [
              "nombre" => "J&#46;"
              "apellidos" => "Borbujo"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731017300443"
        "doi" => "10.1016/j.ad.2016.12.006"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017300443?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017301440?idApp=UINPBA000044"
    "url" => "/15782190/0000010800000006/v1_201706300050/S1578219017301440/v1_201706300050/en/main.assets"
  ]
  "en" => array:15 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letter</span>"
    "titulo" => "Refractory solar urticaria successfully treated with omalizumab with normalization of phototest"
    "tieneTextoCompleto" => true
    "saludo" => "Dear Editor&#44;"
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "593"
        "paginaFinal" => "594"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "A&#46; Combalia, C&#46; Fern&#225;ndez-Sartorio, P&#46; Aguilera"
        "autores" => array:3 [
          0 => array:4 [
            "nombre" => "A&#46;"
            "apellidos" => "Combalia"
            "email" => array:1 [
              0 => "andreacombalia&#64;gmail&#46;com"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "C&#46;"
            "apellidos" => "Fern&#225;ndez-Sartorio"
          ]
          2 => array:2 [
            "nombre" => "P&#46;"
            "apellidos" => "Aguilera"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Dermatology Department&#44; Hospital Cl&#237;nic de Barcelona&#44; Barcelona&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Urticaria solar refractaria tratada satisfactoriamente con omalizumab y normalizaci&#243;n del fototest"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 996
            "Ancho" => 990
            "Tamanyo" => 67385
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">&#40;A&#41; Phototest before omalizumab &#40;Waldman&#174; UV 181 UVA&#41; was positive for UVA&#44; minimal urticarial dose 7<span class="elsevierStyleHsp" style=""></span>J&#47;cm<span class="elsevierStyleSup">2</span>&#46; &#40;B&#41; Phototest after omalizumab &#40;Waldman&#174; UV 181 UVA&#41;&#58; no reaction occurred to UVA after 6 months of treatment&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Solar urticaria &#40;SU&#41; is a rare photodermatosis characterized by sudden onset of urticarial skin lesions&#44; intense itching or burning on photo-exposed areas&#44; occurring a few minutes after sun exposure with great impact on patients&#8217; quality of life&#46; It is considered a type I hypersensitivity reaction&#44; and therefore&#44; it is an immunoglobulin E &#40;IgE&#41;-mediated condition that may be accompanied by other systemic symptoms and signs&#44; such as dizziness&#44; headache and angioedema&#46; The action of spectrum for SU includes ultraviolet A &#40;UVA&#41;&#44; ultraviolet B &#40;UVB&#41;&#44; visible light &#40;VL&#41; and some patients may be sensitive to multiple action spectra&#46; Although the diagnosis is made by the characteristic clinical presentation&#44; it can be confirmed by phototesting&#46;<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">The treatment of choice consists in broad-spectrum sunscreens and high-dose H1-antihistamines&#59; however&#44; SU is often unresponsive to them&#46; Other treatment options are leukotriene receptor antagonists&#44; UV-hardening&#44; cyclosporine A&#44; antimalarial drugs&#44; plasmapheresis and intravenous immunoglobulin &#40;IVIG&#41;&#46; Efficacy of these treatments is usually partial or transient and may induce several unwanted effects&#44; i&#46;e&#46; anaphylaxis&#44; immunosuppression and malignancy&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">Omalizumab is a humanized monoclonal IgG1-kappa antibody against IgE recently approved by the US Food and Drug Administration and the European Medicines Agency for antihistamine refractory patients with chronic spontaneous urticaria &#40;CSU&#41; who are at least 12 years of age&#46;<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">2</span></a> Omalizumab binds to free IgE with a greater affinity than IgE itself binds to the high-affinity Fc¿RI receptors present on basophils&#46; Thus&#44; it reduces the availability of free IgE for binding and promotes down-regulation of Fc¿RI on the surface of mast cells and basophils preventing IgE-mediated histamine release&#46;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">We report a case of a previously healthy 21 year-old Caucasian female with a 4-year history of erythema&#44; intense itch&#44; swelling and hives after minimal sun exposure even through window glass&#46; No history of asthma or food allergy was reported&#46; Phototest performed on the patient&#39;s back &#40;Waldman&#174; UV 181 UVA and Waldman&#174; UV 800 broad band UVB&#41; was positive for UVA&#44; minimal urticarial dose 7<span class="elsevierStyleHsp" style=""></span>J&#47;cm<span class="elsevierStyleSup">2</span>&#44; and showed no reaction to UVB &#40;<a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#41;&#46; Visible light was not tested&#46; IgE serum levels were elevated &#40;294<span class="elsevierStyleHsp" style=""></span>kU&#47;L&#41; and other blood test determinations fell within normal limits&#59; cell count&#44; porphirins&#44; antinuclear antibodies&#44; liver and renal function panel&#44; and serum triptase&#46; She was diagnosed with Solar Urticaria &#40;SU&#41; induced by UVA&#44; and partially achieved to control symptoms with antihistamines &#40;Fexofenadine hydrochloride 180<span class="elsevierStyleHsp" style=""></span>mg&#47;day&#41; and broad-spectrum sunscreens&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0025" class="elsevierStylePara elsevierViewall">Three years after diagnosis&#44; her SU became unresponsive to first-line treatment with antihistamines&#44; even updosing up to 4-fold&#46; Her quality of life&#44; as assessed by the Dermatology Quality of Life Index &#40;DLQI 21&#41; was seriously affected by SU&#46; Thus&#44; after careful consideration we decided to try experimental therapy with omalizumab&#46; Following approval from our institution ethics committee for exceptional medical treatments&#44; an initial dose of 300<span class="elsevierStyleHsp" style=""></span>mg of omalizumab was administered in April 2015&#44; and antihistamines were gradually discontinued&#46; Subsequent doses of 300<span class="elsevierStyleHsp" style=""></span>mg were administered monthly&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">The patient reported a complete relief of symptoms within one day of the administration of the first dose &#40;DLQI 0&#41;&#46; She remained asymptomatic during the Spanish summer and no side effects were noted&#46; However&#44; a delay of omalizumab administration of one week brought back mild urticaria on one occasion&#46; We repeated the phototest six months later to check treatment response and no reaction occurred to either UVA or UVB spectrum &#40;<a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#41;&#46; One year later&#44; she is still on omalizumab and the effect is sustained&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">Treatment of SU with omalizumab is still off-label&#59; however&#44; management of SU with omalizumab has been proved effective on several occasions<a class="elsevierStyleCrossRefs" href="#bib0065"><span class="elsevierStyleSup">3&#8211;9</span></a> and promising clinical results have recently been published&#46;<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a></p><p id="par0040" class="elsevierStylePara elsevierViewall">On a recently published phase-II multicentric study&#44;<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a> the response rate of SU to omalizumab appeared close to the mean proportion of patients with CSU achieving a urticarial activity score over 7 days of 6 or less with the same dose of omalizumab&#44; and&#59; similar to what is observed in CSU&#44; the improvement in solar urticaria was rapidly lost when omalizumab was stopped&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">Omalizumab seems to be a new well-tolerated effective agent in the treatment of severe SU and might be soon included in SU treatment guidelines as a third-line therapy in the same way it is done with CSU&#46;</p><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflict of interest</span><p id="par0050" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflict of interest&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:2 [
        0 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Conflict of interest"
        ]
        1 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "multimedia" => array:1 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 996
            "Ancho" => 990
            "Tamanyo" => 67385
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">&#40;A&#41; Phototest before omalizumab &#40;Waldman&#174; UV 181 UVA&#41; was positive for UVA&#44; minimal urticarial dose 7<span class="elsevierStyleHsp" style=""></span>J&#47;cm<span class="elsevierStyleSup">2</span>&#46; &#40;B&#41; Phototest after omalizumab &#40;Waldman&#174; UV 181 UVA&#41;&#58; no reaction occurred to UVA after 6 months of treatment&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:10 [
            0 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The clinical and photobiological characteristics of solar urticaria in 40 patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "N&#46; Uetsu"
                            1 => "H&#46; Miyauchi-Hashimoto"
                            2 => "H&#46; Okamoto"
                            3 => "T&#46; Horio"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Dermatol"
                        "fecha" => "2000"
                        "volumen" => "142"
                        "paginaInicial" => "32"
                        "paginaFinal" => "38"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10651691"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The EAACI&#47;GA&#40;2&#41; LEN&#47;EDF&#47;WAO Guideline for the definition&#44; classification&#44; diagnosis&#44; and management of urticaria&#58; the 2013 revision and update"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "T&#46; Zuberbier"
                            1 => "W&#46; Aberer"
                            2 => "R&#46; Asero"
                            3 => "C&#46; Bindslev-Jensen"
                            4 => "Z&#46; Brzoza"
                            5 => "G&#46;W&#46; Canonica"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/all.12313"
                      "Revista" => array:6 [
                        "tituloSerie" => "Allergy"
                        "fecha" => "2014"
                        "volumen" => "69"
                        "paginaInicial" => "868"
                        "paginaFinal" => "887"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24785199"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Safety and tolerability of omalizumab &#40;Xolair&#174;&#41;&#44; a recombinant humanized monoclonal anti-IgE antibody"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "Y&#46;M&#46; Deniz"
                            1 => "N&#46; Gupta"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Rev Allergy Immunol"
                        "fecha" => "2005"
                        "volumen" => "29"
                        "paginaInicial" => "31"
                        "paginaFinal" => "48"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16222082"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Successful treatment of solar urticaria with anti-immunoglobulin E therapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "O&#46; G&#252;zelbey"
                            1 => "E&#46; Ardelean"
                            2 => "M&#46; Magerl"
                            3 => "T&#46; Zuberbier"
                            4 => "M&#46; Maurer"
                            5 => "M&#46; Metz"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1398-9995.2008.01879.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Allergy"
                        "fecha" => "2008"
                        "volumen" => "63"
                        "paginaInicial" => "1563"
                        "paginaFinal" => "1565"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18925897"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Church MK2Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria&#58; a retrospective clinical analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "M1 Metz"
                            1 => "T1 Ohanyan"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jdermsci.2013.08.011"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Dermatol Sci"
                        "fecha" => "2014"
                        "volumen" => "73"
                        "paginaInicial" => "57"
                        "paginaFinal" => "62"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24060603"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Three cases of solar urticaria successfully treated with omalizumab"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "C&#46; Baliu-Piqu&#233;"
                            1 => "P&#46; Aguilera Peir&#243;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:2 [
                        "tituloSerie" => "J Eur Acad Dermatol Venereol"
                        "fecha" => "2015"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Successful omalizumab treatment of severe solar urticaria in a 6-year-old child"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "A&#46; Levi"
                            1 => "Y&#46; Tal"
                            2 => "Z&#46; Dranitzki"
                            3 => "M&#46; Shalit"
                            4 => "C&#46;D&#46; Enk"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/pai.12441"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatr Allergy Immunol"
                        "fecha" => "2015 Sep"
                        "volumen" => "26"
                        "paginaInicial" => "588"
                        "paginaFinal" => "590"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26172942"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effectiveness of omalizumab in severe solar urticaria"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "&#193;&#46; De Dios-Vel&#225;zquez"
                            1 => "M&#46; Gonz&#225;lez-de Arriba"
                            2 => "V&#46; Beteta-Gorriti"
                            3 => "E&#46; Macias"
                            4 => "V&#46; Campanon-Toro"
                            5 => "I&#46; Davila"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.anai.2015.12.023"
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Allergy Asthma Immunol"
                        "fecha" => "2016"
                        "volumen" => "116"
                        "paginaInicial" => "260"
                        "paginaFinal" => "262"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26803538"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Treatment with omalizumab in a 16-year-old Caucasian girl with refractory solar urticaria"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46; Arasi"
                            1 => "G&#46; Crisafulli"
                            2 => "L&#46; Caminiti"
                            3 => "F&#46; Guarneri"
                            4 => "T&#46; Aversa"
                            5 => "F&#46; Porcaro"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/pai.12413"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatr Allergy Immunol"
                        "fecha" => "2015 Sep"
                        "volumen" => "26"
                        "paginaInicial" => "583"
                        "paginaFinal" => "585"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26033828"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Omalizumab in patients with severe and refractory solar urticaria&#58; a phase II multicentric study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "F&#46; Aubin"
                            1 => "M&#46; Avenel-Audran"
                            2 => "M&#46; Jeanmougin"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaad.2015.11.021"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Acad Dermatol"
                        "fecha" => "2016"
                        "volumen" => "74"
                        "paginaInicial" => "574"
                        "paginaFinal" => "575"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26892659"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/15782190/0000010800000006/v1_201706300050/S157821901730207X/v1_201706300050/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "6157"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Case and Research Letters"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010800000006/v1_201706300050/S157821901730207X/v1_201706300050/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157821901730207X?idApp=UINPBA000044"
]
Article information
ISSN: 15782190
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 10 9 19
2024 October 65 31 96
2024 September 68 18 86
2024 August 98 52 150
2024 July 82 41 123
2024 June 85 38 123
2024 May 85 41 126
2024 April 70 31 101
2024 March 74 31 105
2024 February 56 26 82
2024 January 48 38 86
2023 December 44 18 62
2023 November 51 27 78
2023 October 51 24 75
2023 September 53 33 86
2023 August 49 19 68
2023 July 64 32 96
2023 June 40 19 59
2023 May 51 24 75
2023 April 41 29 70
2023 March 38 20 58
2023 February 44 25 69
2023 January 27 24 51
2022 December 42 37 79
2022 November 22 31 53
2022 October 35 23 58
2022 September 22 39 61
2022 August 29 35 64
2022 July 16 35 51
2022 June 20 24 44
2022 May 49 42 91
2022 April 50 35 85
2022 March 59 41 100
2022 February 49 23 72
2022 January 54 30 84
2021 December 36 37 73
2021 November 40 44 84
2021 October 46 51 97
2021 September 36 33 69
2021 August 21 32 53
2021 July 19 27 46
2021 June 35 25 60
2021 May 39 51 90
2021 April 77 84 161
2021 March 55 38 93
2021 February 45 29 74
2021 January 29 15 44
2020 December 36 23 59
2020 November 25 21 46
2020 October 24 12 36
2020 September 29 19 48
2020 August 34 16 50
2020 July 26 22 48
2020 June 29 45 74
2020 May 17 16 33
2020 April 28 12 40
2020 March 20 12 32
2020 February 3 0 3
2020 January 4 0 4
2019 December 4 0 4
2019 November 6 0 6
2019 September 4 0 4
2019 August 4 0 4
2019 July 4 0 4
2019 June 4 0 4
2019 May 2 0 2
2019 April 2 0 2
2019 February 3 0 3
2019 January 1 0 1
2018 December 3 0 3
2018 November 3 0 3
2018 October 3 0 3
2018 September 3 0 3
2018 February 12 4 16
2018 January 20 3 23
2017 December 47 6 53
2017 November 16 8 24
2017 October 14 15 29
2017 September 19 13 32
2017 August 38 20 58
2017 July 39 27 66
2017 June 5 1 6
Show all

Follow this link to access the full text of the article

Idiomas
Actas Dermo-Sifiliográficas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?